Bardy Diagnostics™ Selected As Finalist In The Impact Pediatric Health Competition At SXSW 2019 And Advances In The MedTech Innovator Competition

SEATTLE, March 6, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor ("CAM™"), the industry's first P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device, announced it has been selected as a finalist in the fifth annual Impact Pediatric Health Competition to be held at SXSW 2019 on March 8^th. Hosted by the nation's leading pediatric healthcare institutions across the US, the competition invites early stage companies representing the best in pediatric healthcare innovation to present how their products address the unique challenges of this younger patient population.

"It's an honor to be chosen as a finalist amongst such a talented pool of innovative technologies, all aimed at improving the lives of children," said Gust H Bardy, MD, Bardy Diagnostics Founder and Chief Executive Officer. "With our products currently used in children's hospitals across the country, BardyDx is excited for the opportunity to collaborate with the host pediatric healthcare institutions to further advance the CAM patch to meet the unique needs of children and become the standard of care for pediatric ambulatory cardiac monitoring."

BardyDx earned one of the twelve finalist spots to pitch to a distinguished judging panel of venture capitalists, industry leaders, and leading pediatric hospital representatives. Additionally, the Southwest National Pediatric Device Consortium (SWPDC), anchored by Texas Children's Hospital and Baylor College of Medicine, is providing up to $25,000 per awardee to accelerate devices designed to improve the safety and delivery of pediatric care.

"Impact Pediatric Health's reputation for bringing together the leaders in pediatric medical technology innovations makes it the perfect venue to help identify and accelerate the next generation of medical device companies impacting our youngest of patients," said Chester Koh, MD, SWPDC founder and lead principal investigator.

BardyDx and the list of Impact Pediatric Health finalists can be found at https://impactpediatric.health/.

BardyDx Advances in MedTech Innovator Competition

BardyDx also announced today that it was selected to advance to the qualifying round in the MedTech Innovator Competition from a pool of 750 applicants. BardyDx presented earlier this week at the MedTech Innovator Los Angeles Pitch Event, one of the six regional invitation events held over the next few months featuring a total of 150 best-in-class medical device, diagnostic, and digital health companies. Fifty companies will be selected from the MedTech Innovator Pitch round to the Showcase program, which prominently features the most innovative companies from around the world each year at two leading industry conferences: WSGR Medical Device Conference in June and The MedTech Innovator Showcase program at The MedTech Conference, powered by AdvaMed, in September.

About Impact Pediatric Health:

Now in its fifth year, Impact Pediatric Health hosts an annual competition held at SXSW dedicated to showcasing and supporting innovative next generation pediatric healthcare companies focused on digital health and medical devices. Impact Pediatric Health was formed as a collaboration between seven of the largest and top-ranked (according to US News & World Report) children's hospitals in the US, including Children's Healthcare of Atlanta, Boston Children's Hospital, Cincinnati Children's Hospital, Children's Hospital Los Angeles, Seattle Children's Hospital, Stanford Children's Health, and Texas Children's Hospital. Additional information can be found at https://impactpediatric.health/.

About SXSW:

The South by Southwest (SXSW) Conference & Festivals celebrate the convergence of the interactive, film, and music industries. Fostering creative and professional growth alike, SXSW has become the premier destination for discovery and events featuring sessions, showcases, screenings, exhibitions, and a variety of networking opportunities. The Health Track at SXSW focuses on innovations that build and support the ecosystem of patients, providers, payers, policy makers, designers, entrepreneurs, and investors to improve outcomes in health and healthcare. SXSW 2019 will take place March 8-17, 2019. Additional information can be found at www.sxsw.com.  

About MedTech Innovator:

MedTech Innovator is the medical technology industry's nonprofit global competition and accelerator for innovative medical device, digital health, and diagnostic companies. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator is the largest platform of its kind, providing participants with broad exposure and mentorship from the leading players in the medtech industry. Additional information can be found at https://medtechinnovator.org/.

About Bardy Diagnostics:

Bardy Diagnostics, Inc. is an innovator in digital health and remote patient monitoring, with a focus on providing diagnostically-accurate and patient-friendly cardiac patch and other monitors to the industry. The company's CAM patch is a non-invasive, P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device that is designed to improve patient compliance for adults and children through its lifestyle-enabling design. Designed to be worn comfortably and discreetly, the female-friendly, hourglass-shaped CAM patch is placed on the center of the chest, directly over the heart for optimum ECG signal collection. The proprietary technology of the CAM patch provides optimal detection and clear recording of the often difficult-to-detect P-wave, the signal of the ECG waveform that is essential for accurate arrhythmia diagnosis. Additional information can be found at the recently launched redesign of the BardyDx corporate website at www.bardydx.com.

MEDIA CONTACT:
Jonathan Wu
Director, Marketing
Bardy Diagnostics, Inc.
1-844-422-7393
[email protected]

SOURCE Bardy Diagnostics, Inc.

Related Links

http://www.bardydx.com